SCHEMBL4704610

SCHEMBL4704610

O=c1[nH]c2cc(F)c([N+](=O)[O-])cc2[nH]c1=O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIA2 P42262 7/20 0.74
▸ GRIA1 P42261 6/20 0.74
▸ GRIA3 P42263 6/20 0.74
▸ GRIA4 P48058 6/20 0.74
▸ GRIN2D O15399 5/20 0.74
▸ GRIN3B O60391 5/20 0.74
▸ GRIN1 Q05586 5/20 0.74
▸ GRIN2A Q12879 5/20 0.74
▸ GRIN2B Q13224 5/20 0.74
▸ GRIN2C Q14957 5/20 0.74
▸ GRIN3A Q8TCU5 5/20 0.74
▸ GRIK1 P39086 3/20 0.74
▸ GRIK2 Q13002 3/20 0.74
▸ GRIK3 Q13003 3/20 0.74
▸ GRIK4 Q16099 3/20 0.74
▸ GRIK5 Q16478 3/20 0.74
▸ CYP1A2 P05177 2/20 0.74
▸ MAPT P10636 2/20 0.74
▸ LMNA P02545 1/20 0.74
▸ CYP3A4 P08684 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6974351 0.89 MAPT (0.57) GRIA2GRIA1GRIA3GRIA4GRIN2D
SCHEMBL30349886 0.89 MAPT (0.57) GRIA2GRIA1GRIA3GRIA4GRIN2D
Dnqx SCHEMBL594575 0.86 GRIA2 (1.00) GRIA2GRIA1GRIA3GRIA4GRIN2D
SCHEMBL5722914 0.81 GRIA2 (0.50) GRIA2GRIA1GRIA3GRIA4GRIN2D
SCHEMBL5722691 0.81 GRIA2 (0.50) GRIA2GRIA1GRIA3GRIA4GRIN2D
SCHEMBL5722688 0.81 GRIA2 (0.50) GRIA2GRIA1GRIA3GRIA4GRIN2D
SCHEMBL5722909 0.81 GRIA2 (0.50) GRIA2GRIA1GRIA3GRIA4GRIN2D
SCHEMBL5722676 0.80 GRIA2 (0.49) GRIA2GRIA1GRIA3GRIA4GRIN2D
SCHEMBL5722678 0.80 GRIA2 (0.49) GRIA2GRIA1GRIA3GRIA4GRIN2D
SCHEMBL5722674 0.80 GRIA2 (0.49) GRIA2GRIA1GRIA3GRIA4GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013153539-A1 TRICYCLIC COMPOUNDS AS TEC KINASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-10-17 — — WO disclosed
EP-0647137-B1 GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF UNIV CALIFORNIA (US) 2008-08-13 — — EP disclosed
EP-0556393-B1 FUSED PYRAZINE DERIVATIVE YAMANOUCHI PHARMA CO LTD (JP) 2000-07-26 — — EP disclosed
EP-0676397-B1 Oxopyridinylquinoxaline derivatives SHIONOGI & CO (JP) 1999-10-20 — — EP disclosed
US-5677305-A NERVOUS SYSTEM DISORDERS SHIONOGI & CO., LTD. (JP) 1997-10-14 — — US disclosed
US-5622952-A NERVOUS SYSTEM DISORDERS; ADMINISTERING 1,4-DIHYDROQUINOXALINE-2,3-DIONE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-04-22 — — US disclosed
US-5620979-A TREATING NEURONAL LOSS ASSOCIATED WITH STROKE, ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA OR SURGERY STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-04-15 — — US disclosed
US-5514680-A ANTICONVULSANTS WITH 5,6,7-TRISUBSTITUTED-1,4-DIHYDROQUINOXALINE-2,3-DIONE THE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY (US) 1996-05-07 — — US disclosed
EP-0676397-A1 Oxopyridinylquinoxaline derivatives SHIONOGI & CO., LTD. (JP) 1995-10-11 — — EP disclosed
US-5283244-A Anticonvulsants, nervous system disorders YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1994-02-01 — — US disclosed
WO-1994000124-A1 GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF WEBER ECKARD (US) 1994-01-06 — — WO disclosed
EP-0556393-A1 FUSED PYRAZINE DERIVATIVE YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1993-08-25 — — EP disclosed
Send feedback